Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis
Authors:
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 26 (12) , 2863-2874
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MOP-106559, PJT-156261)
- CIHR Frederick Banting and Charles Best Canada Graduate Scholarship
This publication has 87 references indexed in Scilit:
- Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosisTuberculosis, 2012
- Lipid Phenotype of Two Distinct Subpopulations of Mycobacterium bovis Bacillus Calmette-Guérin Tokyo 172 SubstrainJournal of Biological Chemistry, 2011
- Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine ResponsesThe Journal of Infectious Diseases, 2011
- The Stringent Response Is Required for Full Virulence ofMycobacterium tuberculosisin Guinea PigsThe Journal of Infectious Diseases, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosisVaccine, 2009
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human VolunteersThe Journal of Infectious Diseases, 2008
- Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosisProceedings of the National Academy of Sciences, 2007
- Genome plasticity of BCG and impact on vaccine efficacyProceedings of the National Academy of Sciences, 2007
- Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisNature Medicine, 2003